7 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Immunotherapy Adjuvant Trial in Patients With Stage I-III Merkel Cell CarcinomaDNA Virus Infections, Infections, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Tumor Virus Infections, adenocarcinoma, carcinoma, cutaneous neuroendocrine carcinoma, epithelial neoplasm, neoplasm, neuroendocrine carcinoma, neuroendocrine neoplasm, polyomavirus infectious disease, primitive neuroectodermal tumor, viral infectious diseaseActive, not recruitingPhase 22026-10-07NCT04291885
Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.Neoplasm Metastasis, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, neoplasmRecruitingPhase 2 / Phase 32026-10-06NCT06697301
VBC117First-in-Human Trial of VBC117 in Participants With Advanced Malignant Solid TumorsAdvanced Solid TumorsNot yet recruitingPhase 1 / Phase 22026-09-22NCT07772934
A Study of DM002 in Patients With Advanced Solid TumorsAdnexal Diseases, Digestive System Diseases, Digestive System Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, colonic disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, endocrine system disorder, endometrium neoplasm, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, intestinal disorder, male reproductive organ cancer, male reproductive system disorder, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, ovarian cancer, ovarian disorder, pancreas disorder, pancreatic neoplasm, prostate cancer, prostate disorder, rectal disorder, uterine disorderRecruitingPhase 1 / Phase 22026-08-07NCT06751329
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Antitumor Activity of ALK201 in Participants With Advanced Solid TumorsAdvanced Cancer; Advanced Solid TumorsRecruitingPhase 1 / Phase 22026-05-22NCT06656390
A First-in-human Study of IBI343 in Subjects With Locally Advanced Unresectable or Metastatic Solid TumorsLocally Advanced Unresectable or Metastatic Solid TumorsRecruitingPhase 12026-05-04NCT05458219
A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.B-cell neoplasm, Bites and Stings, Cancer of the Uterine Cervix, Chemically-Induced Disorders, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Head and Neck Neoplasms, Hemic and Lymphatic Diseases, Male Urogenital Diseases, Neoplasm Metastasis, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, Skin and Connective Tissue Diseases, Urogenital Diseases, Urogenital Neoplasms, Uterine Cervical Neoplasms, Uveal Neoplasms, benign urinary system neoplasm, breast disorder, breast neoplasm, carcinoma, cervix disorder, diffuse large B-cell lymphoma, epithelial neoplasm, eye disorder, female reproductive system disorder, female reproductive system neoplasm, follicular lymphoma, head and neck squamous cell carcinoma, immune system disorder, immunoproliferative disorder, in situ carcinoma, injury, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, mantle cell lymphoma, melanocytic neoplasm, melanoma, metastatic malignant neoplasm, neoplasm, neuroendocrine neoplasm, ocular cancer, poisoning, primitive neuroectodermal tumor, skin disorder, skin neoplasm, squamous cell carcinoma, triple-negative breast carcinoma, urinary bladder cancer, urinary bladder disorder, urinary bladder neoplasm, urinary system disorder, uterine disorder, uveal disorder, uveal melanomaRecruitingPhase 12025-12-24NCT06022029